









Biofilm control by ionic liquids
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Ionic liquids (ILs) are remarkable chemical compounds with applications in many areas of modern
science. They are increasingly recognized as promising compounds to fight microorganisms in both
planktonic and biofilm states, contributing to reinvent the antimicrobial pipeline. Biofilm-related
infections are particularly challenging given that the scientific community has not yet identified a
reliable control strategy. Understanding of the action of ILs in biofilm control is is still in a very early
stage. However, given the highly tunable nature and exceptional properties of ILs, they are excellent
candidates for biofilm control. Here, we review the major advances in, and challenges tothe use of ILs for
effective biofilm control.
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Microorganisms are typically found adhered on
biotic or abiotic surfaces as complex sessile
communities embedded in a matrix of extra-
cellular polymeric substances (EPS) that they
produce [1,2]. According to the National Insti-
tute of Health, it is estimated that 80% of mi-
crobial infections in humans are biofilm related
and affect 1.4 million people annually [3], pro-
moting disease transmission, prolonged hospi-
talization and additional clinical procedures,
thus increasing healthcare costs, and mortality
and morbidity rates [4,5]. Most bacterial-asso-
ciated infections, including endocarditis, dental
caries, middle ear infections, osteomyelitis,
medical device-related infections, and chronic
lung infections in patients with cystic fibrosis,
are problematic or untreatable because of bio-
films. The pathological process of biofilm for-
mation in human infections is a multifactorial
event that can be divided in four main steps
(Fig. 1) [6].1340 www.drugdiscoverytoday.comThe presence of biofilms is associated with the
failure of conventional antimicrobial therapeutic
approaches, with antibiotic resistance being of
particular concern when bacteria form biofilms.
Antibiotic concentrations necessary to inhibit
bacterial biofilms can be up to 10–1000 times
higher than those needed to inhibit the same
bacteria grown planktonically [7]. In addition to
resistance mechanisms found in planktonic cells
(gene transfer from resistant counterparts, efflux
pumps, cellular impermeability imparted by the
outer layers, enzymes that confer resistance, and
natural evolutionary mutations) [8], there are
several mechanistic hypothesis to explain the
increased resistance of biofilms to antimicro-
bials: (i) direct interactions between the biofilm
EPS and antimicrobials, affecting diffusion and
availability; (ii) existence of an altered chemical
microenvironment within the biofilm leading to
areas of reduced or no growth (dormant cells);
(iii) development of biofilm-specific phenotypes;
(iv) ability of microorganisms in biofilms toexpress specific resistance genes; (v) possibility
of damaged bacterial cells undergoing pro-
grammed cell death; and (vi) existence of per-
sister cells [2,7]. With a dearth of new antibiotic
and/or antibiofilm agents in the pipeline and
ever-decreasing pharmaceutical industry in-
volvement in the discovery of new drugs, there
is a pressing need to find novel and innovative
solutions.
ILs are increasingly recognized as relevant for
antimicrobial purposes [9–13]. They are gener-
ally referred to as ‘green solvents’ because they
fulfill all the 12 principles of Green Chemistry
laid down by Paul Anastas and John Warner [14].
The ability to tune the physical, chemical, and
biological properties of ILs by independent
modification of the properties of each constit-
uent (cationic head and tail, and anion), has
been the major driving force behind the interest
in their biomedical applications. Moreover, ILs
have also been at the cutting edge for the
development of prodrugs or drug delivery1359-6446/ã 2021 Elsevier Ltd. All rights reserved.
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FIGURE 1
The main steps and processes involved in the development of infectious biofilms. Classically, four steps are considered: (1) initial adhesion followed by (2)
microcolony formation, in which chemical interactions and signaling pathways are dominant allowing the formation of the matrix of extracellular polymeric
substances (EPS). At that step, antimicrobial resistant bacteria appear as a consequence of the microcolony structure and composition. (3) Biofilm maturation is
characterized by the formation of a 3D structure, where the EPS production, chemical signaling events, and the generation of resistant bacteria occur to a high
extent, leading to the formation of recalcitrant infections. (4) As a biofilm matures, detachment events also occur, spreading cells and fragments of the biofilm to






systems to solve problems related to solubility
and permeability issues [15,16]. ILs were also
found to be able to dissolve complex biopoly-
mers [17], an effect of potential interest when
searching for a strategy to disrupt the complex
EPS matrix of biofilms. Here, we review the major
achievements in, and challenges to the use of ILs
as a new generation of therapeutic agents for
effective biofilm control.
Ionic liquids: an overview
ILs are molten salts (most of them melt below
100 C) consisting entirely of charged speciesFIGURE 2
Most commonly described cations and anions of ion
(nonheterocyclic and heterocyclic) and nonaromatic; t
The chemical structures of each system are provided(ions), with most being liquid at room temper-
ature [18–20]. Recent reviews focused on recent
advances in IL synthesis, organization, and
modulation of physicochemical properties were
published [15,21–24]. Currently, ILs are catego-
rized in different generations, with the first and
second-generation IL generally focused on
modulation of physicochemical properties and
applications, respectively. Third-generation ILs
(advanced or task-specific ILs) were based on
the use of biodegradable and natural ions or
ions with known pharmacological activity, such
as active pharmaceutical ingredients (API)ic liquids (ILs) used in biomedical studies. IL cations a
he anions are organic or inorganic and biobased. The ta
 elsewhere [9,15,21–26].[9,15,22,25]. The exploitation of ILs relevant
chemical space is currently of interest for bio-
medical and pharmaceutical applications.
The versatile properties of ILs, in conjunction
with their potential for multiple functionalities,
provide a myriad of innovative antimicrobial
strategies with the chemical diversity needed for
antimicrobial drug discovery programs and to
progress the control of antimicrobial-resistant
microorganisms [25]. ILs antimicrobial proper-
ties fully depend on their structure, which can be
adjusted by altering the cationic organic head
(positive charge usually located on the nitrogenDrug Discovery Today 
re categorized into two main types: aromatic


















or phosphorus atoms) the tail (usually an alkyl
linear chain with a variable length) and the
organic/inorganic or biobased anion (Fig. 2)
[21,26]. The enormous range of cation–anion
combinations, with some estimates as high as
1018 when in multiphase mixtures, results in a
large potential for the adjustability of IL struc-
ture and properties [27,28]. The cations and
anions of ILs commonly used in biomedical and
pharmaceutical studies are described in Fig. 2.
Ionic liquids as antimicrobials
Generally, ILs display antimicrobial activity to-
ward a range of bacteria as well as mycobacteria
and fungi. However, the highest activity of ILs is
seen in relation to Gram-positive cocci, such as
Staphylococcus and Streptococcus and other
Gram-positive bacteria, including Lactobacillus
and Bacillus subtilis [25]. The biocidal properties
of ILs is defined by the molecular architecture of
each one that is mainly dictated by the structure
of the cationand in particular by the length of
the aliphatic alkyl chains (Fig. 2) [9].
The most common IL cationic head groups
include imidazolium, pyridinium, quinolinium,
morpholinium, pyrrolidinium, and choline ions
(Fig. 2) [9]. Nonaromatic ILs are usually less toxic
than those containing heterocyclic nitrogen
rings [29–32]. In general, their antimicrobial
















Examples of (a) dicationic ionic liquids (DILs) containin
nalidixic acid) and quaternary ammonium ILs.
1342 www.drugdiscoverytoday.comthe introduction of substituents on the cationic
head [33]. Quinolinium ILs are generally more
potent than imidazolium ILs [34], with 1-alkyl-
quinolinium ILs being one of the most potent
antimicrobial ILs [9,35]. Relevant effects on the
activity were found when a tail is present in the
IL system (Fig. 2). An increase in chain length by
extending the number of alkyl groups can in-
crease the IL–cell surface affinity [36] and en-
hance their antimicrobial activity. A higher
hydrophobicity of a surface-active compound
results in a lower concentration needed for
microbial growth control [37].
The most effective antimicrobial effects have
been reported for ILs containing alkyl chains
with 10–16 carbon atoms. The data showed that
a balance between hydrophilicity and lipophi-
licity is crucial for the antimicrobial performance
[15,38]. Quinoline-based ILs, such as the 1-
alkylquinolinium ILs, showed the highest anti-
microbial activity when the alkyl chain was 12–
14-carbons long [39]. Pyrrolidinium ILs con-
taining an alkyl chain with 14 carbon atoms
display the highest antimicrobial activity against
bacteria and fungi [31]. Nevertheless, the per-
formance of ILs is strongly dependent on the
type of cation because it has a significant role in
determining the hydrophilic–lipophilic balance
required. For example, trihexyl(alkyl)phospho-











g phosphonium and imidazolium cations and (b) duacarbons are effective antimicrobials because
they are able to easily penetrate the peptido-
glycan cell wall of Gram-positive bacteria [40].
Although both cation and anions (Fig. 2) in-
trinsic to ILs can have inherent antimicrobial
activity, varying the anion for the same cation
does not appear to affect their outline [31].
However, for ILs with small organic cations, the
chaotropicity of the anion can be a major con-
tributor to their antimicrobial action because
anions are typically chemical penetration
enhancers [41,42]. This phenomenon was ob-
served for some phosphonium-based ILs [43].
Another approach of potential interest is the
use of amino acids (e.g., proline, tryptophan,
phenylalanine, methionine, and valine) as
anions [9]. ILs with imidazolium cations and
tryptophan anions demonstrated potent anti-
bacterial activity against both Gram-negative
and Gram-positive bacteria [44]. Within this
framework, the choline-geranate ILs (Fig. 2) are
gaining interest because of their excellent an-
timicrobial activity [42]
Dicationic ILs (DILs) comprise two head
groups (cations) linked by a rigid or flexible
spacer and two anions. They are usually classi-
fied as homoanionic and heteroanionic dica-
tionic ILs. DILs have a high ionic character and
their properties can be tuned by changing the
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cation/anion. DILs have attracted increasing
interest as antimicrobials because their hydro-
phobicity, efficacy,/selectivity, and toxicity can
be tailored [15,28,45–47]. In fact, DILs containing
imidazolium, benzimidazolium, pyridinium,
ammonium and phosphonium counter cations
have been described as potential antimicrobial
agents. Examples of DILs used in antimicrobial
studies are shown in Fig. 3a [48].
Ionic liquids and drug delivery
The use of ILs for drug delivery purposes has
been recently reviewed [15,16,49–51]. Generally,
they are used to modify drug pharmacokinetic
properties, such as solubility, stability, and/or
permeability across biological membranes, or in
formulations.
Monocationic ILs are used carriers to increase
the efficiency and reduce adverse effects of
antimicrobial drugs. They typically work as
bacterial membrane permeabilizers. There are
several successful examples from the use of
synergistic permeation enhancers, such as 1-
octyl-3-methylimidazolium-based ILs, choline
and terpene-bioinspired ILs, and amine-based
ILs, among others [52]. However, there is little
published information available related to the
application of dicationic ILs, and their benefits,
in drug delivery. Based on this concept, and
inspired by IL chemistry, dual-active API-ILs
have also been developed. In this regard, active
antimicrobial drugs can act as anion or cation
moieties and ILs as the counter ions. The dual
effect of API-ILs is dependent on the hydro-
philicity/hydrophobicity of the counter ion,
which can be used as a modulating factor for
tuning the solubility and activity against vari-
ous bacterial strains [53,54]. The API-IL concept
has been extended to improve the perfor-
mance of several antibiotics, such as ampicillin,
ciprofloxacin, norfloxacin, nalidixic acid, peni-
cillin G, amoxicillin, colistin, and antimicrobial
peptides. The combination of 1-butyl-3-
methylimidazolium chloride and 1-butyl-3-
methylimidazolium tetrafluoroborate with
polymyxin B enhanced bacterial membrane
disruption and, thus- the antibiotic efficacy [55].
The most studied is the combination of ampi-
cillin with quaternary ammonium ILs (Fig. 3b)
[35]. Ampicillin has also been successfully
paired with various organic cations, such as
imidazolium, pyridinium, and choline [56].
Generally, this type of API-ILs are more effective
against Gram-positive than Gram-negative
bacteria,because of the absence of an outer
membrane in the former, and can decrease the
ampicillin concentration required for the anti-
microbial effects [35].The use of nano-based ILs approaches to
develop drugdelivery systems by nanoencap-
sulation of antimicrobial drugs is limited. Thus
far, ILs have been used to functionalize or coat
silver, gold, and zinc oxide nanoparticles (NPs).
This type of NPs demonstrated to be synergic in
terms of antimicrobial activity against diverse
bacteria [39,57–60]. Such combinations have a
high surface area:volume ratio and unique
chemical, physical, and antimicrobial properties
[61]. In addition, nano-assembled systems, such
as those based on phosphonium salts, have
been used with positive outcomes [62].
Antimicrobial mode of action of ionic
liquids
Antimicrobial ILs share structural and mecha-
nistic analogies with cationic biocides, such as
quaternary ammonium compounds (QACs), the
primary mode of action of which is membrane-
bound protein disruption [31,63]. In effect,
mechanistic studies have shown that ILs target
mainly the cytoplasmic (inner) membrane in
bacteria and the plasma membrane in yeast [37],
which leads to changes in the structural and
dynamic properties of the outer layers [25] and
subsequent disruption and loss of membrane
integrity [64]. The general mechanism of action
is based on the fact that most bacterial cells are
negatively charged, often stabilized by the
presence of divalent cations, such as Ca2+ and
Mg2+, and that antimicrobial ILs are positively
charged [65]. Therefore, during the first stage of
antimicrobial action, there is an interaction
between the cationic head group of ILs and the
negative structural proteins of the bacterial
outer layers [66]. Then, cations are readily
absorbed into the cell layers, connecting to the
cytoplasmatic membrane, and penetrating the
interior of the cell [67]. ILs further provoke the
coagulation of cytoplasmic constituents causing
the inhibition of crucial enzymes (i.e., acetyl-
cholinesterase, AMP deaminase, acylase I, cy-
tochrome c oxidase, glutathione reductase,
carboxylesterase, catalase, and Taq DNA poly-
merase), interfering with energy or self-repair
processes [68,69], and finally causing cell death
[38].
Additionally, ILs tend to aggregate in solution
to form amphiphilic micelles and as such display
surface activity [9]. This ability to form micelles
limits the number of free cations in solution and,
thus, represents an upper concentration cut-off.
However, they display an enhanced ability to
peel off patches of lipids from the bilayer,
forming new micelles of mixed composition and
greater stability [67]. This affinity of ILs for bio-
molecules, particularly lipids, is related to thesimilarity of their structure and opportunity for
intermolecular interactions [67].
Ionic liquids against microbial biofilms
There is a growing interest in using ILs for
biofilm control, as there are no known chemical
entity able to effectively kill biofilm cells and, at
the same time, cause biofilm disruption/re-
moval. Moreover, it is possible to inactivate a
biofilm without causing its dispersal (i.e., biofilm
inactivation and removal are distinct phenom-
ena). Within this framework, some ILs have
shown the ability to control biofilm growth and
cause the disruption of the complex 3D struc-
ture, a phenomenon relevant to enhance anti-
biotic diffusion. As well as their potential dual
action as antimicrobial and antibiofilm agents,
ILs have also been reported for their plasticizing
effects on surface materials commonly used in
the production of functionalized medical
devices with antiadhesive properties [42,70].
Table 1 provides examples of ILs used in
biofilm control studies. Imidazolium-based ILs
are the systems most frequently used in biofilm
control [58,60,61], although some research has
highlighted the applicability of other ILs with
different cationic heads, such as quinolinium,
pyridinium, phosphonium, and choline. Gener-
ally, the antibiofilm performance of ILs is mod-
ulated by the length of the tail, increasing with
the increase of the alkyl chain length [71].
Compounds from a library of 1-alkyl-3-
methylimidazolium chloride ILs showed signifi-
cant antibiofilm activity against a range of
clinically important Gram-positive bacteria, with
1-decyl-3-methylimidazolium chloride being
highlighted for the strongest activity [31]. From
a library of quinolone-based ILs, 1-alkylquinoli-
nium bromide salts with 12 and 14 carbons in
the alkyl chain demonstrated strong antibiofilm
effects against diverse bacterial pathogens [34].
Imidazolium-based monocationic and dicationic
ILs with an anthracene moiety covalently at-
tached to the imidazolium efficiently inhibited
the biofilms of Gram-positive bacteria [69] Fur-
thermore, a recent study reported the syner-
gistic bactericidal and antibiofilm activities of 1-
alkyl-3-methylimidazolium ILs, with the incor-
poration of anions containing silver or copper,
against Pseudomonas aeruginosa and Staphylo-
coccus aureus [39].
Pyridinium ILs, including bisalkylpyridinium
derivatives, were proposed to be used as topical
agents to control biofilm infections [48]. Choi
et al. reported the dual functional of ILs where
1-ethylpyridinium docusate and tributyl(2-
hydroxyethyl)phosphonium docusate were
proposed for the decontamination of hospitalwww.drugdiscoverytoday.com 1343
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TABLE 1
Examples of ILs with relevant antibiofilm activity.
IL family Compound(s) Microorganism Effects Refs
Imidazole
1-Dodecyl-3-methylimidazolium iodide




Candida tropicalis Biofilm inhibition [76]





(incorporated in polymeric nanoparticles)
Staphylococcus epidermidis Biofilm inhibition [78]
1-Octyl-3-methylimidazolium chloride







1-Alkylquinolinium bromides with variable length chain
















Methicillin-resistant S. aureus Biofilm inhibition [56,73]
Choline
Choline-geranate
P. aeruginosa, Salmonella enterica Biofilm inhibition [42]
Dialkylamine
N,N-Diethyl-N-methyl-N-(2-methoxyethyl)ammonium
bis(trifluoro methanesulfonyl)imide (for polymer brush
coating)
Escherichia coli, S. epidermidis Biofilm dispersal [80]
N,N-Diethyl-N-(2-methancryloylethyl)-N-methylammonium























surfaces, because they act as both antimicrobial
and antibiofilm-forming agents [73].
Current trends in ILs research highlight cho-
line-based ILs as promising for the control of
pathogenic biofilms. In particular, choline ger-
anate demonstrated strong effects against bio-
films of Salmonella enterica and Pseudomonas
aeruginosa, and an increased delivery of the
antibiotic cefadroxil by >16-fold into the deep
tissue layers of the skin without inducing skin
irritation [41]. The in vivo efficacy of choline
geranate was further validated in a P. aeruginosa
biofilm-infected wound model, proposing the
use of ILs for simultaneous enhancement of
topical drug delivery and antibiotic activity.
More recently, innovative N-alkylimidazolium ILs
functionalized with plant secondary metabolites
(phytochemicals) of the shikimate pathway,
such as p-coumaric and cinnamic acids, and with
different chain lengths, were developed. They
demonstrated antibiofilm activity against Gram-
negative and Gram-positive bacteria, with the
strongest potency being found for derivatives
that contained alkyl chains of eight and ten
carbons [74]. 1-Cinnamoyl-3-octyl-1H-imidazol-
3-ium bromide was revealed to be the strongest
IL [74]. The same strategy has been implemen-
ted using amino acids as modifiers of the imi-
dazolium cation [70].
Concluding remarks
ILs are remarkable chemical compounds with
diverse pharmaceutical and biotechnological
applications. Given their broad chemical space
and highly tunable nature, they are relevant
players in drug discovery and drug delivery
projects. With the drugdiscovery pipeline cur-
rently clogged, ILs could be exploited as an
interesting strategy to tackle pathogens. Cur-
rent knowledge highlights the potential of ILs
to control microbial growth in both planktonic
and biofilm states. However, even if ILs are
promising for biofilm control, through the in-
activation of the colonizer cells and the dis-
ruption of the extracellular polymeric ties,
further studies are needed to understand their
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